# Energizer Holdings, Inc.: financial statements, quarterly

ENR · NYSE · CIK 1632790 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/enr.md) · [Financials](/companies/enr/financials.md) · [Filings](/companies/enr/filings.md) · [Insiders](/companies/enr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/enr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [811 d](/filings/0001632790-25-000091.md) | [717](/filings/0001632790-25-000024.md) | [663](/filings/0001632790-25-000040.md) | [701](/filings/0001632790-25-000066.md) | [806 d](/filings/0001632790-25-000091.md) | [732](/filings/0001632790-26-000038.md) | [663](/filings/0001632790-26-000056.md) | [725](/filings/0001632790-26-000076.md) | [833 d](/filings/0001632790-25-000091.md) | [779](/filings/0001632790-26-000038.md) | [643](/filings/0001632790-26-000056.md) | [734](/filings/0001632790-26-000076.md) |
| Cost of revenue | $m | [504 d](/filings/0001632790-25-000091.md) | [450](/filings/0001632790-25-000024.md) | [410](/filings/0001632790-25-000040.md) | [424](/filings/0001632790-25-000066.md) | [499 d](/filings/0001632790-25-000091.md) | [462](/filings/0001632790-26-000038.md) | [404](/filings/0001632790-26-000056.md) | [326](/filings/0001632790-26-000076.md) | [528 d](/filings/0001632790-25-000091.md) | [522](/filings/0001632790-26-000038.md) | [385](/filings/0001632790-26-000056.md) | [454](/filings/0001632790-26-000076.md) |
| Gross profit | $m | [307 d](/filings/0001632790-25-000091.md) | [267](/filings/0001632790-25-000024.md) | [253](/filings/0001632790-25-000040.md) | [277](/filings/0001632790-25-000066.md) | [307 d](/filings/0001632790-25-000091.md) | [270](/filings/0001632790-26-000038.md) | [259](/filings/0001632790-26-000056.md) | [400](/filings/0001632790-26-000076.md) | [304 d](/filings/0001632790-25-000091.md) | [257](/filings/0001632790-26-000038.md) | [259](/filings/0001632790-26-000056.md) | [281](/filings/0001632790-26-000076.md) |
| Research and development | $m | [8.5 d](/filings/0001632790-25-000091.md) | [7.8](/filings/0001632790-25-000024.md) | [7.9](/filings/0001632790-25-000040.md) | [7.4](/filings/0001632790-25-000066.md) | [8.5 d](/filings/0001632790-25-000091.md) | [8.0](/filings/0001632790-26-000038.md) | [8.1](/filings/0001632790-26-000056.md) | [8.2](/filings/0001632790-26-000076.md) | [8.3 d](/filings/0001632790-25-000091.md) | [7.8](/filings/0001632790-26-000038.md) | [7.6](/filings/0001632790-26-000056.md) | [7.4](/filings/0001632790-26-000076.md) |
| Selling, general and administrative | $m | [135 d](/filings/0001632790-25-000091.md) | [128](/filings/0001632790-25-000024.md) | [123](/filings/0001632790-25-000040.md) | [130](/filings/0001632790-25-000066.md) | [146 d](/filings/0001632790-25-000091.md) | [131](/filings/0001632790-26-000038.md) | [136](/filings/0001632790-26-000056.md) | [128](/filings/0001632790-26-000076.md) | [137 d](/filings/0001632790-25-000091.md) | [149](/filings/0001632790-26-000038.md) | [133](/filings/0001632790-26-000056.md) | [129](/filings/0001632790-26-000076.md) |
| Interest expense | $m | [41.6 d](/filings/0001632790-25-000091.md) | [40.7](/filings/0001632790-25-000024.md) | [38.7](/filings/0001632790-25-000040.md) | [38.5](/filings/0001632790-25-000066.md) | [37.8 d](/filings/0001632790-25-000091.md) | [37.0](/filings/0001632790-26-000038.md) | [38.0](/filings/0001632790-26-000056.md) | [39.0](/filings/0001632790-26-000076.md) | [40.3 d](/filings/0001632790-25-000091.md) | [39.1](/filings/0001632790-26-000038.md) | [39.3](/filings/0001632790-26-000056.md) | [39.7](/filings/0001632790-26-000076.md) |
| Income tax | $m | [2.9 d](/filings/0001632790-25-000091.md) | [7.5](/filings/0001632790-25-000024.md) | [10.0](/filings/0001632790-25-000040.md) | [(13.7)](/filings/0001632790-25-000066.md) | [11.9 d](/filings/0001632790-25-000091.md) | [7.8](/filings/0001632790-26-000038.md) | [8.1](/filings/0001632790-26-000056.md) | [10.7](/filings/0001632790-26-000076.md) | [18.5 d](/filings/0001632790-25-000091.md) | [(1.4)](/filings/0001632790-26-000038.md) | [11.6](/filings/0001632790-26-000056.md) | [9.9](/filings/0001632790-26-000076.md) |
| Net income | $m | [19.7 d](/filings/0001632790-25-000091.md) | [1.9](/filings/0001632790-25-000024.md) | [32.4](/filings/0001632790-25-000040.md) | [(43.8)](/filings/0001632790-25-000066.md) | [47.6 d](/filings/0001632790-25-000091.md) | [22.3](/filings/0001632790-26-000038.md) | [28.3](/filings/0001632790-26-000056.md) | [154](/filings/0001632790-26-000076.md) | [34.9 d](/filings/0001632790-25-000091.md) | [(3.4)](/filings/0001632790-26-000038.md) | [10.1](/filings/0001632790-26-000056.md) | [39.9](/filings/0001632790-26-000076.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | [0.03](/filings/0001632790-25-000024.md) | [0.45](/filings/0001632790-25-000040.md) | [(0.61)](/filings/0001632790-25-000066.md) | not reported | [0.31](/filings/0001632790-26-000038.md) | [0.39](/filings/0001632790-26-000056.md) | [2.16](/filings/0001632790-26-000076.md) | not reported | [(0.05)](/filings/0001632790-26-000038.md) | [0.15](/filings/0001632790-26-000056.md) | [0.58](/filings/0001632790-26-000076.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [223](/filings/0001632790-24-000102.md) | [242](/filings/0001632790-24-000022.md) | [158](/filings/0001632790-24-000038.md) | [147](/filings/0001632790-24-000063.md) | [217](/filings/0001632790-25-000091.md) | [196](/filings/0001632790-25-000024.md) | [139](/filings/0001632790-25-000040.md) | [171](/filings/0001632790-25-000066.md) | [236](/filings/0001632790-26-000076.md) | [215](/filings/0001632790-26-000038.md) | [173](/filings/0001632790-26-000056.md) | [173](/filings/0001632790-26-000076.md) |
| Current assets | $m | [1,557](/filings/0001632790-24-000102.md) | [1,471](/filings/0001632790-24-000022.md) | [1,358](/filings/0001632790-24-000038.md) | [1,393](/filings/0001632790-24-000063.md) | [1,479](/filings/0001632790-25-000091.md) | [1,406](/filings/0001632790-25-000024.md) | [1,395](/filings/0001632790-25-000040.md) | [1,642](/filings/0001632790-25-000066.md) | [1,679](/filings/0001632790-26-000076.md) | [1,563](/filings/0001632790-26-000038.md) | [1,500](/filings/0001632790-26-000056.md) | [1,600](/filings/0001632790-26-000076.md) |
| Total assets | $m | [4,510](/filings/0001632790-24-000102.md) | [4,424](/filings/0001632790-24-000022.md) | [4,287](/filings/0001632790-24-000038.md) | [4,241](/filings/0001632790-24-000063.md) | [4,342](/filings/0001632790-25-000091.md) | [4,230](/filings/0001632790-25-000024.md) | [4,212](/filings/0001632790-25-000040.md) | [4,516](/filings/0001632790-25-000066.md) | [4,557](/filings/0001632790-26-000076.md) | [4,444](/filings/0001632790-26-000038.md) | [4,399](/filings/0001632790-26-000056.md) | [4,466](/filings/0001632790-26-000076.md) |
| Current liabilities | $m | [734](/filings/0001632790-24-000102.md) | [724](/filings/0001632790-24-000022.md) | [668](/filings/0001632790-24-000038.md) | [701](/filings/0001632790-24-000063.md) | [820](/filings/0001632790-25-000091.md) | [783](/filings/0001632790-25-000024.md) | [750](/filings/0001632790-25-000040.md) | [924](/filings/0001632790-25-000066.md) | [795](/filings/0001632790-26-000076.md) | [784](/filings/0001632790-26-000038.md) | [732](/filings/0001632790-26-000056.md) | [772](/filings/0001632790-26-000076.md) |
| Total liabilities | $m | [4,299](/filings/0001632790-24-000102.md) | [4,253](/filings/0001632790-24-000022.md) | [4,096](/filings/0001632790-24-000038.md) | [4,118](/filings/0001632790-24-000063.md) | [4,207](/filings/0001632790-25-000091.md) | [4,090](/filings/0001632790-25-000024.md) | [4,078](/filings/0001632790-25-000040.md) | [4,333](/filings/0001632790-25-000066.md) | [4,387](/filings/0001632790-26-000076.md) | [4,302](/filings/0001632790-26-000038.md) | [4,226](/filings/0001632790-26-000056.md) | [4,263](/filings/0001632790-26-000076.md) |
| Long-term debt | $m | [3,332](/filings/0001632790-24-000102.md) | [3,303](/filings/0001632790-24-000022.md) | [3,226](/filings/0001632790-24-000038.md) | [3,213](/filings/0001632790-24-000063.md) | [3,193](/filings/0001632790-25-000091.md) | [3,117](/filings/0001632790-25-000024.md) | [3,155](/filings/0001632790-25-000040.md) | [3,218](/filings/0001632790-25-000066.md) | [3,408](/filings/0001632790-26-000076.md) | [3,319](/filings/0001632790-26-000038.md) | [3,305](/filings/0001632790-26-000056.md) | [3,295](/filings/0001632790-26-000076.md) |
| Current portion of debt | $m | [12.0](/filings/0001632790-24-000102.md) | [12.9](/filings/0001632790-24-000022.md) | [12.8](/filings/0001632790-24-000038.md) | [12.7](/filings/0001632790-24-000063.md) | [12.0](/filings/0001632790-25-000091.md) | [13.0](/filings/0001632790-25-000024.md) | [6.6](/filings/0001632790-25-000040.md) | [8.4](/filings/0001632790-25-000066.md) | [10.1](/filings/0001632790-26-000076.md) | [10.0](/filings/0001632790-26-000038.md) | [10.2](/filings/0001632790-26-000056.md) | [10.2](/filings/0001632790-26-000076.md) |
| Shareholders' equity | $m | [211](/filings/0001632790-25-000091.md) | [171](/filings/0001632790-25-000066.md) | [191](/filings/0001632790-25-000066.md) | [123](/filings/0001632790-25-000066.md) | [136](/filings/0001632790-26-000076.md) | [141](/filings/0001632790-26-000076.md) | [134](/filings/0001632790-26-000076.md) | [183](/filings/0001632790-26-000076.md) | [170](/filings/0001632790-26-000076.md) | [141](/filings/0001632790-26-000076.md) | [173](/filings/0001632790-26-000076.md) | [203](/filings/0001632790-26-000076.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [98.9 d](/filings/0001632790-25-000091.md) | [178](/filings/0001632790-25-000024.md) | [36.8 d](/filings/0001632790-25-000040.md) | [45.8 d](/filings/0001632790-25-000066.md) | [169 d](/filings/0001632790-25-000091.md) | [77.0](/filings/0001632790-26-000038.md) | [(12.8) d](/filings/0001632790-26-000056.md) | [21.4 d](/filings/0001632790-26-000076.md) | [61.5 d](/filings/0001632790-25-000091.md) | [150](/filings/0001632790-26-000038.md) | [(1.7) d](/filings/0001632790-26-000056.md) | [8.2 d](/filings/0001632790-26-000076.md) |
| Capital expenditure | $m | [21.4 d](/filings/0001632790-25-000091.md) | [25.5](/filings/0001632790-25-000024.md) | [26.5 d](/filings/0001632790-25-000040.md) | [18.5 d](/filings/0001632790-25-000066.md) | [27.4 d](/filings/0001632790-25-000091.md) | [34.6](/filings/0001632790-26-000038.md) | [21.0 d](/filings/0001632790-26-000056.md) | [13.5 d](/filings/0001632790-26-000076.md) | [14.8 d](/filings/0001632790-25-000091.md) | [25.3](/filings/0001632790-26-000038.md) | [17.7 d](/filings/0001632790-26-000056.md) | [9.1 d](/filings/0001632790-26-000076.md) |
| Dividends paid | $m | [21.5 d](/filings/0001632790-25-000091.md) | [22.7](/filings/0001632790-25-000024.md) | [21.5 d](/filings/0001632790-25-000040.md) | [21.6 d](/filings/0001632790-25-000066.md) | [21.6 d](/filings/0001632790-25-000091.md) | [23.6](/filings/0001632790-26-000038.md) | [21.7 d](/filings/0001632790-26-000056.md) | [21.3 d](/filings/0001632790-26-000076.md) | [20.5 d](/filings/0001632790-25-000091.md) | [23.3](/filings/0001632790-26-000038.md) | [20.6 d](/filings/0001632790-26-000056.md) | [20.6 d](/filings/0001632790-26-000076.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001632790-25-000091.md) | [0.0](/filings/0001632790-26-000038.md) | [0.0 d](/filings/0001632790-26-000056.md) | [62.6 d](/filings/0001632790-26-000076.md) | [27.1 d](/filings/0001632790-25-000091.md) | [4.5](/filings/0001632790-26-000038.md) | [0.9 d](/filings/0001632790-26-000056.md) | [0.0 d](/filings/0001632790-26-000076.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [72.2](/filings/0001632790-24-000022.md) | [72.4](/filings/0001632790-24-000038.md) | [72.5](/filings/0001632790-24-000063.md) | [72.6](/filings/0001632790-25-000024.md) | [72.6](/filings/0001632790-25-000040.md) | [71.8](/filings/0001632790-25-000066.md) | [73.2](/filings/0001632790-26-000038.md) | [73.3](/filings/0001632790-26-000056.md) | [72.1](/filings/0001632790-26-000076.md) | [68.4](/filings/0001632790-26-000038.md) | [69.1](/filings/0001632790-26-000056.md) | [69.2](/filings/0001632790-26-000076.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 68,483,637 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001632790-26-000076.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.